The joint application between Regenetek Therapies and CCSVI Clinic has been approved through the IEC Institutional Review Board (IRB) that will allow researchers to use patient data to study their new extended and enhanced aftercare treatment protocol. The study hypothesis states that in MS patients with CCSVI undergoing endovascular treatment, those receiving the enhanced hospital [...]

Canadian-based MS patients of CCSVI Clinic have recently returned home from their 10-day procedural liberation therapy at CCSVI Clinic in Pune, India. Both the treatment and trip was an unqualified success for the entire group. Most patients have seen remarkable and positive improvements in their deficits both while in the hospital and since their return [...]